The Best Joint Supplement for Dogs: Nutramax Cosequin Ds Plus with Msm Chewable Tablets
Nutramax Cosequin Ds Plus with Msm Chewable Tablets are joint supplements made by Nutramax Corporation. They have been developed to improve joint health in dogs. These products contain the active ingredient called chelates, which help prevent bone loss and preserve cartilage.
There are several types of chelated substances available, such as chondroitin sulfate (CS), hydroxypropyl methylcellulose (HPMC) and hydroxyethyl cellulose (EUC). All these materials help prevent osteoarthritis, arthritis and other diseases in humans. However, they do not appear to affect human bones or joints.
So far there is no evidence that they cause any harm in animals either.
Chelation therapy is used to treat certain conditions in humans, including high blood pressure, heart disease and cancer. In addition to treating those conditions, it may also reduce the risk of developing osteoporosis. Chelation therapy involves injecting patients with radioactive material or other chemicals that bind to heavy metals in the body.
When these metals accumulate in the body’s tissues or organs, they can lead to various diseases and even death. This treatment has successfully improved the health of some patients suffering from heart disease, kidney failure and other illnesses.
Another use of chelation therapy is for treating metal poisoning. This method is also used to extract toxic metals such as lead, arsenic and mercury from the body. By removing these substances through chelation, doctors are able to treat certain conditions such as lead poisoning, heavy metal poisoning and arsenic poisoning.
Sources & references used in this article:
- 5 Ways to Support Your Dog’s Joint Health (S Sinatra – agelesspaws.com)
- Nutrition for working and service dogs (J Wakshlag, J Shmalberg – Veterinary Clinics: Small Animal …, 2014 – vetsmall.theclinics.com)
- Combining a joint health supplement with tibial plateau leveling osteotomy in dogs with cranial cruciate ligament rupture. An exploratory controlled trial (FM Martini, AB de Bellesini, A Miolo, L Del Coco… – International journal of …, 2017 – Elsevier)
- Clinical use of an herbal-derived compound (Huperzine A) to treat putative complex partial seizures in a dog (BM Schneider, NH Dodman, D Faissler, N Ogata – Epilepsy & Behavior, 2009 – Elsevier)